GridAI Technologies Corp(GRDX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
October 8 at 4:02 PM ET (Korea 10/9 05:02)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -4.3 | Insider Own | 14.75% | Shs Outstand | 6.9M | Perf Week | 39.53% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 6.1M | Perf Month | 58.94% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | - | Inst Own | 8.95% | Short Float | 0.9% | Perf Quarter | 6.67% |
| Income | -0.02B | P/S | 213.93 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.54 | Perf Half Y | 120.18% |
| Sales | 0.00B | P/B | 2.3 | EPS next 5Y | - | ROA | -32.94% | Short Interest | 0.05M | Perf YTD | 3% |
| Book/sh | 2.09 | P/C | 24.8 | EPS past 3/5Y | 85.07% 88.24% | ROE | -56.5% | 52W High | -30.73% ($6.93) | Perf Year | 20% |
| Cash/sh | 0.19 | P/FCF | - | Sales past 3/5Y | - | ROIC | -111.81% | 52W Low | 156.68% ($1.87) | Perf 3Y | -75.76% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 61.09% | Gross Margin | -815.6% | Volatility(W/M) | 13.19% 11.88% | Perf 5Y | -99.99% |
| Dividend TTM | - | EV/Sales | 270.87 | Sales Y/Y TTM | - | Oper. Margin | -7655.42% | ATR (14) | 0.45 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.16 | EPS Q/Q | -195.47% | Profit Margin | -12999.98% | RSI (14) | 69.41 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.16 | Sales Q/Q | - | SMA20 | 35.42% ($3.54) | Beta | 1.77 | Target Price | $108 |
| Payout | - | Debt/Eq | 0.1 | Earnings | - | SMA50 | 38.57% ($3.46) | Rel Volume | 2.05 | Prev Close | $4.12 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 149.35% - | SMA200 | 39.69% ($3.44) | Avg Volume(3M) | 0.10M | Price | $4.8 |
| IPO | 2016/10/11 | Option/Short | No/Yes | Trades | 1059 | Volume | 207,481 | Change | 16.5% |
⚡ This company develops an AI-powered software platform that performs real-time energy orchestration for AI data centers, power companies, and large electricity consumers. In addition to its Aggregation Management Platform, which integrates grid management, on-site generation, battery storage, and electricity market participation for full optimization, it is an ultra-small-cap Nasdaq-listed company that still holds legacy pharmaceutical assets from its past research into gastrointestinal disease treatments.
Over the past 1 year, roughly in the middle
31% below its 1-year high.
Traded more than usual That is 205% of its average volume.
GRDX has weak earnings and a weak balance sheet
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $21,393. Peers typically go for $1,168.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -100.0%. The S&P 500 did +77% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 8.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
DFSU Dimensional US Sustainability Core 1 ETF <0.01% 
VXF Vanguard Extended Market Index ETF <0.01% It ranks #446 of 592 in the industry
Based on market cap of $34M.
CVM#445 Cel-Sci Corp $34M PER - GRDX#446 GridAI Technologies Corp $34M PER - 
BCTX#447 BriaCell Therapeutics Corp $34M PER - 
ATNM#448 Actinium Pharmaceuticals Inc $34M PER 3.0 
NNVC#449 NanoViricides Inc $33M PER - 
FAQ
What kind of company is GRDX?
GRDX belongs to the Healthcare sector and operates in the Biotechnology industry.
What is the market cap of GRDX?
The market cap of GRDX is approximately $34M, ranking 5,086 within its sector.
What is the 52-week high and low for GRDX?
GRDX has recorded a 52-week high of $6.93 and a low of $1.87.
